Skip to content Skip to footer

2007

Conference Publication

Heparan sulfate mimetics - potent angiogenesis inhibitors for cancer therapy

Dredge, K, Davis, K, Liu, L, Johnstone, K, Handley, P, Wimmer, N, Bytheway, I, Hammond, E, Li, CP, Rowley, J, Ferro, V and Gautam, A (2007). Heparan sulfate mimetics - potent angiogenesis inhibitors for cancer therapy. AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, San Francisco, CA, United States, 22-26 October 2007. Philadelphia, PA, United States: American Association for Cancer Research.

Heparan sulfate mimetics - potent angiogenesis inhibitors for cancer therapy

2006

Conference Publication

Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells

Wimmer, N, Robinson, JA, Gopisetty-Venkatta, N, Roberts-Thomson, SJ, Monteith, GR and Toth, I (2006). Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells. 19th American Peptide Symposium, San Diego, CA, United States, June 18-23 2005. New York, N.Y., United States: Springer. doi: 10.1007/978-0-387-26575-9_148

Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells

2006

Conference Publication

Development of peptide vaccines against HPV-16 associated cervical cancer and group a streptococci

Moyle, Peter M., Horvath, Aniko, Karpati, Levente, Olive, Colleen, Barozzi, Nadia, Wimmer, Norbert, Good, Michael and Toth, Istvan (2006). Development of peptide vaccines against HPV-16 associated cervical cancer and group a streptococci. 19th American Peptide Symposium, San Diego, United States, 18-23 June 2005. New York, United States: Springer. doi: 10.1007/978-0-387-26575-9_169

Development of peptide vaccines against HPV-16 associated cervical cancer and group a streptococci

2005

Conference Publication

Anti-proliferative effects of novel glyco-lipoaminoacid-modified arsenicals (III) on MCF-7 human breast cancer cells

Wimmer, N., Robinson, J. A., Thomson, S. J., Monteith, G. R. and Toth, I. (2005). Anti-proliferative effects of novel glyco-lipoaminoacid-modified arsenicals (III) on MCF-7 human breast cancer cells. 19th American Peptide Symposium, San Diego, U.S., 18-23 June, 2005. Hoboken, U.S.: Wiley Interscience.

Anti-proliferative effects of novel glyco-lipoaminoacid-modified arsenicals (III) on MCF-7 human breast cancer cells

2004

Conference Publication

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

Toth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E.P. (2004). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. 18th American Peptide Symposium, Boston, 19-23 July, 2004.

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

2003

Conference Publication

Use of synthetic dendrimer peptide's to mediate the delivery of a sense oligonucleotide

Marano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Toth, I., Wilson, A. S., Brankov, M. and Rakoczy, P. E. (2003). Use of synthetic dendrimer peptide's to mediate the delivery of a sense oligonucleotide. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology, Ft Lauderdale Florida, May, 2003. Rockville, MD United States: Association for Research in Vision and Ophthalmology.

Use of synthetic dendrimer peptide's to mediate the delivery of a sense oligonucleotide

2003

Conference Publication

Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery

Marano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Toth, I., Wilson, A. S., Brankov, M. and Rakoczy, P. E. (2003). Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery. 3rd Meeting of the Australasian-Gene-Therapy-Society, Brisbane Australia, Apr 30-May 02, 2003. CHICHESTER: Wiley.

Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery

2003

Conference Publication

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

Toth, I., Horvath, A., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E. P. (2003). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. 26th Australian Polymer Symposium, Noosa, Queensland, 13-17 July 2003. Australia: Royal Australian Chemical Institute.

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

2003

Conference Publication

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

Toth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E. P. (2003). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. Brisbane Biological and Organic Chemistry Symposium, Gold Coast, 28 November, 2003.

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

2002

Conference Publication

Use of brucine to crystallise a disaccharide from a bacterial source

Gould, R. O., Walkinshaw, M. D., Wimmer, N. and Kosma, P. (2002). Use of brucine to crystallise a disaccharide from a bacterial source. XIX IUCr Congress, Geneva, Switzerland, August 2002. International Union of Crystallography (IUCr). doi: 10.1107/s0108767302090050

Use of brucine to crystallise a disaccharide from a bacterial source

2001

Conference Publication

Synthesis of cationic lipidic peptide dendrimer vectors for in vitro oligonucleotide delivery.

Kearns, P. S., Wimmer, N., Rakoczy, P. E. and Toth, I. (2001). Synthesis of cationic lipidic peptide dendrimer vectors for in vitro oligonucleotide delivery.. APSA Annual Conference 2001, Melbourne, 9-12 Dec 2001. Melbourne: Australasian Pharmaceutical Science Association.

Synthesis of cationic lipidic peptide dendrimer vectors for in vitro oligonucleotide delivery.